Leaving the EU with a deal remains the Government’s top priority. This has not changed.
However a responsible government must plan for every eventuality, including a no deal scenario.
This guidance will apply from exit day in line with the Human Medicines Regulations (Amendment etc.) (EU Exit) Regulations 2019.
If the UK leaves the EU without a deal, supply chains for products sourced from the European Union and European Economic Area (EEA) may be affected by changes to border processes and procedures. At the request of the Department of Health and Social Care (DHSC), pharmaceutical companies have been contingency planning to ensure continuity of supply. These measures include building stockpiles and using air freight to avoid any border delays.
The shipment of medicines by air freight requires specific control measures. This guidance provides advice on Good Distribution Practice (GDP) requirements for air freight to ensure that product quality and security is protected.